PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 114 filers reported holding PROVENTION BIO INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,141 | +119.0% | 47,345 | -4.1% | 0.00% | 0.0% |
| Q4 2022 | $521 | -99.7% | 49,380 | +37.4% | 0.00% | – |
| Q3 2022 | $161,000 | -16.6% | 35,933 | -25.7% | 0.00% | – |
| Q2 2022 | $193,000 | +11.6% | 48,366 | +103.8% | 0.00% | – |
| Q1 2022 | $173,000 | +183.6% | 23,737 | +115.5% | 0.00% | – |
| Q4 2021 | $61,000 | -79.1% | 11,013 | -68.6% | 0.00% | – |
| Q3 2021 | $292,000 | -11.5% | 35,067 | -10.5% | 0.00% | – |
| Q2 2021 | $330,000 | +164.0% | 39,177 | +430.0% | 0.00% | – |
| Q4 2020 | $125,000 | -38.4% | 7,392 | -53.3% | 0.00% | – |
| Q3 2020 | $203,000 | +24.5% | 15,842 | +36.3% | 0.00% | – |
| Q2 2020 | $163,000 | +162.9% | 11,619 | +71.1% | 0.00% | – |
| Q1 2020 | $62,000 | -38.6% | 6,792 | -0.5% | 0.00% | – |
| Q4 2019 | $101,000 | +114.9% | 6,824 | -1.6% | 0.00% | – |
| Q3 2019 | $47,000 | – | 6,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 14,879,023 | $157,271,273 | 9.67% |
| MPM BioImpact LLC | 898,483 | $9,496,965 | 2.46% |
| VR Adviser, LLC | 1,118,653 | $11,824,162 | 1.99% |
| Ghost Tree Capital, LLC | 400,000 | $4,228,000 | 1.80% |
| EAM Investors, LLC | 276,250 | $2,919,963 | 0.60% |
| EAM Global Investors LLC | 209,856 | $2,218,178 | 0.57% |
| 683 Capital Management, LLC | 550,000 | $5,813,500 | 0.49% |
| Palo Alto Investors LP | 390,800 | $4,130,756 | 0.35% |
| CABOT WEALTH MANAGEMENT INC | 184,271 | $1,948 | 0.33% |
| ADVISORY RESEARCH INC | 288,707 | $3,051,633 | 0.29% |